Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Anna Baran, MD
Advertisement
Articles by Anna Baran, MD
Applied Clinical Trials
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Advertisement
Latest Updated Articles
- Initial Design Considerations for Immuno-Oncology Trials
August 13th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Comparing OpenAI and Mistral on Clinical Trial Matching
4
What FDA Inspections Reveal About the Quality of APAC Clinical Trial Sites
5